This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Hefei Amvite Pharmaceutical Co., Ltd, Hefei Industrial Pharmaceutical Institute Co., Ltd. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 2 Years Active: 2021-2022
Title: Innovations by Qinlong Xu in Pharmaceutical Technology
Introduction
Qinlong Xu is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceutical technology, particularly in the treatment of skin inflammatory diseases. With a total of 2 patents, his work showcases innovative approaches to medicinal chemistry.
Latest Patents
One of Qinlong Xu's latest patents is a compound pharmaceutical composition for treating skin inflammatory diseases. This invention focuses on a compound that combines tofacitinib and crisaborole, resulting in a stronger therapeutic effect and lower dosage requirements. The composition demonstrates a significant synergistic therapeutic effect, making it a promising option for treating various skin inflammatory conditions.
Another important patent by Xu involves a compound that inhibits phosphodiesterase 4 (PDE-4). This small molecule compound, along with its preparation method and pharmaceutical applications, has shown efficacy in inflammation treatment. Pharmacodynamic tests confirm the compound's inhibitory activity on the PDE-4 enzyme, highlighting its potential in medicinal chemistry.
Career Highlights
Qinlong Xu has worked with reputable companies in the pharmaceutical industry, including Hefei Industrial Pharmaceutical Institute Co., Ltd and Hefei Amvite Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Qinlong Xu has collaborated with various professionals in his field, including his coworker Zhaoxing Chu. These collaborations have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Qinlong Xu's contributions to pharmaceutical technology, particularly in treating skin inflammatory diseases, demonstrate his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing medicinal chemistry and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile